Starting
Initialising…
0%
TP53
Final classification
Likely Pathogenic
TP53 c.722C>A · p.Ser241Tyr
TP53

The TP53 NM_000546.6:c.722C>A (p.Ser241Tyr, p.S241Y) variant has been observed in somatic cancers in COSMIC (COSV52713934, 54 occurrences) and has been reported in ClinVar as Pathogenic by 4 clinical laboratories and Likely Pathogenic by 1 clinical laboratory.

Gene
TP53
Transcript
NM_000546.6
HGVS · transcript:coding
NM_000546.6:c.722C>A
Consequence
N/A
GRCh38
chr17:7674241 G>T
GRCh37
chr17:7577559 G>T
Basis Official TP53 VCEP/CSPEC v2.4.0 point-based final-classification framework (Tavtigian et al., 2020 Bayesian adaptation of ACMG/AMP) was applied to the adjudicated criteria.
Official TP53 VCEP/CSPEC v2.4.0 point-based final-classification framework (Tavtigian et al., 2020 Bayesian adaptation of ACMG/AMP) was applied to the adjudicated criteria.
Classification rationale
PS3PM2PP3 Likely Pathogenic
TP53 c.722C>A

The TP53 NM_000546.6:c.722C>A (p.Ser241Tyr, p.S241Y) variant has been observed in somatic cancers in COSMIC (COSV52713934, 54 occurrences) and has been reported in ClinVar as Pathogenic by 4 clinical laboratories and Likely Pathogenic by 1 clinical laboratory.1 This variant is absent from gnomAD v2.1 and has 0/1,613,928 alleles in gnomAD v4.1, which is below the TP53 VCEP PM2_Supporting threshold of 0.00003.2 TP53 VCEP functional data support loss of p53 function for p.Ser241Tyr, with non-functional Kato results and loss of function in the majority of other eligible assays, supporting PS3.3 TP53-specific in silico evidence supports a deleterious effect, with Align-GVGD Class C65, BayesDel 0.544682, a pre-assigned PP3_moderate code, and SpliceAI showing no significant predicted splice impact (max delta score 0.01).4

PS3 + PM2 + PP3 Likely Pathogenic
3 vcep_f_u_n_c_t_i_o_n_a_l___w_o_r_k_s_h_e_e_toncokb ↗PMID:12826609 ↗PMID:29979965PMID:30224644PMID:25584008 ↗
4 vcep_p_p_3___b_p_4___c_o_d_e_sspliceai ↗
Gene diagram · NM_000546.6 · variants mapped to exon structure
TP53 NM_000546.6
Fetching transcript structure from UCSC…
Applied criteria · 3 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports pathogenic
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 0; MAF= 0.00000%, 0/1613928 alleles, homozygotes = 0) and has highest observed frequency in the African/African American population (AF= 0; MAF= 0.00000%, 0/74982 alleles, homozygotes = 0).
      v2.1
      Absent from gnomAD v2.1.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      Absent · 0 / 1,613,928
      0 hom
      Not observed in any ancestry group.
      + 10 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, South Asian, Ashkenazi Jewish, African/African American, European (non-Finnish))
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Pathogenic (4 clinical laboratories) and as Likely pathogenic (1 clinical laboratory).
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.01).
      Functional / OncoKB screenshot
      Functional Likely Oncogenic
      OncoKB classifies this variant as Likely Oncogenic; biological effect: Loss-of-function.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant lies in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV52713934, n = 54 times).
      Hotspots
      This variant lies in a statistically significant hotspot.
      Literature · how each cited paper was used
      6papers cited
      Each card is an audit: what was searched, what was found, whether it names the variant, which criteria it fed, and why.
      Understanding the function-structure and function-mutation relationships of p53
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PS3 supports · met
      Prevalence and spectrum of germline mutations of the p53 gene among patients wit
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PP3 supports · met
      Prevalence and functional consequence of TP53 mutations in pediatric adrenocorti
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PS3 supports · met
      Allele-specific wild-type TP53 expression in the unaffected carrier parent of ch
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PP3 supports · met
      PMID 29979965
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PS3 supports · met
      PMID 30224644
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PS3 supports · met
      Sources & reference links
      8Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots